Archive for Immunotherapy (Targeted)

A Phase I/II, Open-label Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of FB849 Administered in Subjects with Advanced Solid Tumors Alone and in Combination with Pembrolizumab

A Phase 1 study of BAL0891 as monotherapy and in combination with chemotherapy in patients with advanced solid tumors

A Phase 1/2 Study of ASP1570 in Participants with Locally Advanced or Metastatic Solid Tumors